{"claimId":"clm_ec_b6-omega3-blood-sugar","grade":"B","version":0,"status":"current","verdict":"Omega-3 for blood sugar: Grade B at moderate certainty. Meta-analysis in type 2 diabetes: results for omega-3 on glucose control were mixed and, overall, no consistent improvement in glycemic control was demonstrated. The authors note the EPA/DHA ratio and early intervention may modify effects — a subgroup signal, not a general glucose benefit.","direction":"benefit","magnitude":{"metric":"other","value":null,"unit":"","ci95":null,"humanReadable":"Meta-analysis in type 2 diabetes: results for omega-3 on glucose control were mixed and, overall, no consistent improvement in glycemic control was demonstrated. The authors note the EPA/DHA ratio and early intervention may modify effects — a subgroup signal, not a general glucose benefit.","baselineAbsoluteRisk":null},"certainty":"moderate","clinicalMeaning":"small_but_potentially_useful","applicability":{"appliesTo":["adults with type 2 diabetes"],"doesNotApply":[],"unknown":[]},"safetyQualifiers":["serious_with_warfarin"],"evidenceBundleId":"eb_ec_b6-omega3-blood-sugar","citations":[{"pmid":"26431431","design":"peer-reviewed"}],"reviewedBy":null,"reviewedAt":"2026-07-16T16:23:25.159Z","dateModified":"2026-07-16T16:23:25.159Z","methodologyVersion":"v1","methodologyDoi":"https://doi.org/10.5281/zenodo.21364236","canonicalUrl":"https://evidencebased.info/interventions/omega-3/blood-sugar","attribution":"Substrate (evidencebased.info), claim clm_ec_b6-omega3-blood-sugar v0, reviewed 2026-07-16","license":"CC-BY-4.0 proposed; reuse license pending governance ratification","governanceMode":"legacy","governanceStatus":"legacy-unverified","dataSource":"live"}